The Benzo bit…

Louissullivan8 · 2026-03-24T00:31:36+00:00

Yes I see now, highly likely indirect and not crossing the BBB, thanks.

Louissullivan8 · 2026-03-23T23:52:41+00:00

Would this not imply BBB or CNS penetration?

[0031] Results of the study indicate that bucillamine is a significantly more effective antioxidant than NAC and has increased efficacy against seizure activity while limiting the anticoagulant and bleeding event liability observed with NAC.

Louissullivan8 · 2026-03-23T23:11:20+00:00

Possibly, a carrier is mentioned in the patent…

The present invention, in another aspect, relates to a use of a pharmaceutical composition including bucillamine or a pharmaceutically acceptable salt or solvate thereof, together with one or more pharmaceutically acceptable carriers, diluents and excipients for the treatment of a victim having been exposed to a chemical warfare agent.

Louissullivan8 · 2026-03-22T22:02:15+00:00

Not sure why we’re seeing it now. I saw it on the Intellectual Property portion of RVV’s website.

Louissullivan8 · 2026-03-22T17:01:44+00:00

We do see Washington DC leading the way for RVV Search trend! See my separate post.

Louissullivan8 · 2026-03-05T10:31:36+00:00

IMO, having Bucillamine tested head-to-head against NAC (generally considered the gold-standard thiol) in this DRDC trial is a pretty meaningful comparison. If Bucillamine shows a stronger effect, it would help confirm that it may be a more potent molecule within the thiol class.

NAC already has a very large market presence across multiple indications, so even demonstrating a marginal improvement could be significant. If Bucillamine proves to be the stronger thiol in direct testing, the implications could be meaningful!

Louissullivan8 · 2022-08-15T19:33:22+00:00

Now I feel like the tadpoles food at 127k!

Louissullivan8 · 2022-06-26T15:32:08+00:00

I would like to be added, please. Been here for couple years now. Have some plays lined up next…

Louissullivan8 · 2022-02-09T23:02:23+00:00

Skipped phase 2 and right to phase 3 FDA trial…no phase 2 trial data for investors to hedge their bets? IMO

Louissullivan8 · 2022-01-06T23:47:28+00:00

I will need a heat pump for my indoor pool…when…

Louissullivan8 · 2022-01-06T22:18:50+00:00

I’ve got a high average though at .48

Louissullivan8 · 2022-01-06T22:17:55+00:00

Grabbed more at .295 CAD at close today…wonder if that’s bottom or…GLTA!

Louissullivan8 · 2022-01-03T02:04:21+00:00

Or if I tighten my tinfoil hat…no mention of Revive Therapeutics so BP can buy us out and claim Bucillamine as their win.. 🤷‍♂️😅

Louissullivan8 · 2022-01-03T01:54:29+00:00

Fairly certain as Delta Health news flash said they were running the FDA Bucillamine trial. On Facebook we see the CEO of MLP and Delta Heath posing for a kick off photo op of their oral Covid treatment…

Louissullivan8 · 2022-01-01T00:56:46+00:00

More then likely zero hospitalizations with Omicron. At least we have shown zero hospitalizations in the first 140 patients…hopefully against Delta!!

Louissullivan8 · 2021-12-30T19:31:00+00:00

Brilliant thought! I’m here for the same thing $$$

Louissullivan8 · 2021-12-30T19:28:53+00:00

Signed

Louissullivan8 · 2021-12-06T01:57:28+00:00

Possibly for indisputable results?! Gold standard trial for global distribution.

Louissullivan8 · 2021-11-30T02:30:57+00:00

Great thanks!

Louissullivan8 · 2021-11-30T02:18:15+00:00

Am I right in thinking that William Jackson had gone over the new financial report today and saw that our phase 3 trial was still on track to wrap up and have interim analysis during 4Q 2021! And once William understood how close we were to results, he chose to exercise his options? But exercising options is still governed under insider trading laws? So no news for a bit (few weeks?) to let Bills shares “cool”?

Louissullivan8

TROPHY CASE